Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30014102HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30014108HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30047831HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30047832HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30047833HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30017454HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS20032025HPVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS20022411HPVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS20020749HPVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TCGA Plot Options
Drug Information
GeneTYK2
DrugBank IDDB11817
Drug NameBaricitinib
Target IDBE0004146
UniProt IDP29597
Regulation Typeinhibitor
PubMed IDs30871014
CitationsMayence A, Vanden Eynde JJ: Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases. Pharmaceuticals (Basel). 2019 Mar 12;12(1). pii: ph12010037. doi: 10.3390/ph12010037.
GroupsApproved; Investigational
Direct ClassificationPyrrolo[2,3-d]pyrimidines
SMILESCCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
Pathways
PharmGKB
ChEMBLCHEMBL2105759